Clinical trial Recruiting at 1 site Observational Ages 6 Months to 90

Registry for understanding gastroparesis and related motility disorders

Official title: Indiana University GI Neuromuscular Pathology Prospective Registry

Run by Indiana University · NCT02165059 · Data updated 2026-11-12

This study is trying to understand the causes of gastroparesis and related digestive issues by collecting samples and information from patients having surgery for these conditions.

More Gastroparesis trials

Quick facts

Study typeObservational
Ages6 Months to 90 Years
SexAll
Enrollment300 (estimated)
SponsorIndiana University
Academic / other
Locations1 site (Indianapolis, Indiana)
StatusRecruiting
StartedDecember 1, 2013
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJune 16, 2026
Trial IDNCT02165059 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients diagnosed with gastroparesis who are scheduled for surgical biopsy and those undergoing specific digestive surgeries without gastroparesis.

Probably not a fit

Patients with significant comorbidities, contraindications for biopsy, or prior diagnoses of gastroparesis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects biopsy samples from patients diagnosed with gastroparesis who are undergoing gastric electrical stimulation implantation surgery. It also includes a control group of patients without gastroparesis undergoing various digestive surgeries. The study aims to investigate the underlying causes of motility disorders, assess symptom severity through questionnaires, and follow patients over 24 months to evaluate outcomes. The collected data will help direct future investigations and improve prognosis for patients with these conditions.

Why it matters

Potential benefit: If successful, this study could lead to better understanding and management of gastroparesis, improving treatment options for patients.

How similar studies have gone: While similar studies have explored motility disorders, this specific registry approach focusing on biopsy samples is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria Study Group:

Patients who are undergoing surgical full-thickness biopsy of the stomach and/or proximal jejunum for the clinical evaluation of GI neuromuscular disorder.

Inclusion Criteria Control Group:

Patients undergoing esophagectomy, sleeve gastrectomy for obesity, or Roux-en Y gastric bypass Patients undergoing Whipple surgery Patients undergoing transplant surgery

Patients who are organ donors and undergoing surgery

Exclusion Criteria Study Group:

Contraindication for surgical full-thickness biopsy for any reason. Significant comorbidity due to severe cardiovascular, renal, pulmonary, or liver disease.

Significant coagulopathy Non-ambulatory patients: bed-ridden, nursing home resident. Pregnant Unable to give own informed consent Prisoners

Exclusion Criteria Control Group:

Prior diagnosis of gastroparesis Prior diagnosis of chronic intestinal pseudo-obstruction Unable to give own informed consent if not an organ donor

Where it's running

  • Indiana University Hosptial
    Indianapolis, Indiana, United States
    Recruiting

Study contacts

  • Principal investigator: John M Wo, MD — Indiana University
  • Study coordinator: Maureen M Schilling, MD
  • Email: maschi@iu.edu

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.